Table 3.

Activities of fluconazole and investigational antifungal agents against 1,184 BSI isolates of Candida spp. from four geographic regions (SENTRY Program, 1997 to 1999)

Antifungal agentMIC (μg/ml) and % susceptible by countrya
U.S. (n = 589)Canada (n = 161)Latin America (n = 132)Europe (n = 302)
50/90%% S50/90%% S50/90%% S50/90%% S
Fluconazole0.25/16900.25/4960.25/4980.25/890
Ravuconazole0.015/0.25980.015/0.12990.015/0.25990.007/0.598
Voriconazole0.015/0.25980.015/0.12990.015/0.12990.007/0.2599
  • a n, no. tested. U.S., United States. % S, percent susceptible at a MIC of ≤8 μg/ml (fluconazole) or ≤1 μg/ml (all other agents).